16-year-old girl with Parry-Romberg syndrome presented with monolateral exudative neuroretinitis and retinal telangiectasis that had been observed for 42 months. She was treated with immunosuppressive therapy with A-cyclosporine for I year, followed by laser treatment of telangiectasis. Her visual acuity improved from 20/200 to 20/70 in I year with a reduction of neuroretinal exudation. Laser treatment resulted in a further improvement of visual acuity to 20/40. Clinical findings remained unchanged during 2 years of follow-up. The association of immunosuppressive treatment and laser therapy may improve neuroretinal disease in the presence of Parry-Romberg syndrome.
Clinical evolution of neuroretinitis in Parry-Romberg syndrome / DE CRECCHIO, Giuseppe; Forte, R; Strianese, D; Rinaldi, M; D'Aponte, A.. - In: JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS. - ISSN 0191-3913. - STAMPA. - 45:2(2008), pp. 125-126.
Clinical evolution of neuroretinitis in Parry-Romberg syndrome.
DE CRECCHIO, GIUSEPPE;Strianese D;Rinaldi M;
2008
Abstract
16-year-old girl with Parry-Romberg syndrome presented with monolateral exudative neuroretinitis and retinal telangiectasis that had been observed for 42 months. She was treated with immunosuppressive therapy with A-cyclosporine for I year, followed by laser treatment of telangiectasis. Her visual acuity improved from 20/200 to 20/70 in I year with a reduction of neuroretinal exudation. Laser treatment resulted in a further improvement of visual acuity to 20/40. Clinical findings remained unchanged during 2 years of follow-up. The association of immunosuppressive treatment and laser therapy may improve neuroretinal disease in the presence of Parry-Romberg syndrome.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
